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Abstract 
Introduction: In this study, we examined the effects of Brucella infection on endothelial dysfunction. Flow-mediated dilatation (FMD) 
measurement is indicator of the endothelial function, and abnormal values indicating endothelial dysfunction are accepted as the first stage of 
atherosclerosis.  
Methodology: Twenty-four patients who had been treated for acute brucellosis two years before, and who had had no relapses in the follow-
up, were prospectively included in the study, along with 30 healthy individuals in the control group. Results: While the highly sensitive C-
reactive protein (hs-CRP) value was 2.42 ± 1.45 in the patient group, it was 1.72 ± 0.61 in the control group (p = 0.025). While the FMD 
value was 3.50 ± 1.58 in the patient group, it was 5.88 ± 1.88 in the control group (p < 0.001). While the percentage increase in FMD was 
9.88 ± 4.92 in the patient group, it was 17.49 ± 6.3 in the control group (p < 0.001). It was observed that FMD value, the percentage increase 
in FMD, and basal radius were correlated with hs-CRP (r = -0.644, p < 0.001; r = - 0.558, p = 0.002; r = 0.444, p = 0.018, respectively). The 
carotid artery intima media thickness (IMT) value was found to be 0.61 ± 0.17 in the patient group and 0.49 ± 0.12 in the control group (p = 
0.004). 
Conclusions: The abnormal FMD and IMT values observed in brucellosis patients might be an indicator of more frequent arterial 
dysfunction, increased cardiovascular risk, and atherosclerosis. 
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Introduction 
Brucellosis is a zoonotic disease, frequently 
encountered in developing countries, that constitutes 
an important public health problem [1]. It can infect 
people especially through contaminated meat, milk, or 
dairy products, as well as through direct contact with 
the excrements and secretions of infected animals [2]. 
Brucella are small, Gram-negative and facultative, 
intracellular, pathogenous bacteria that invade 
mononuclear phagositic system cells to increase in 
them [3]. Brucellosis is an inflammatory disease that 
may involve any organ or system in the body [4]. It 
can lead to serious cardiovascular complications by 
affecting endothelial cells and provoking a strong 
inflammatory response. The secretion of adhesion 
molecules and proinflammatory chemokines during a 
Brucella infection plays an important role in the 
activation of the endothelial system. This 
inflammatory response, as well as the immunological 
reactions that develop against the Brucella antigens in 
the vessel wall, are responsible for the pathogenesis of 
the damage that results in the vascular system [5]. The 
dysfunction observed in the endothelial system is one 
of the first changes that occur in the pathogenesis of 
cardiovascular diseases, and is encountered in various 
clinical conditions [6]. The measurement technique of 
flow-mediated dilatation (FMD) has been developed in 
the last decade to assess the endothelium-dependent 
function of the vascular system following an occlusion 
in the brachial artery. 
 
Nitric oxide (NO) is secreted and vasodilatation 
develops as a result of the stimulation of the 
endothelium, a situation that is considered to be a sign 
of vasomotor function. Ultrasound imaging of the 
reactive hyperaemia in the brachial artery is used to 
calculate the endothelium-dependent vasomotor 
function [7]. 
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The state of the carotid arteries gives an idea about 
the state of the coronary arteries. In most of the 
patients with carotid artery obstruction, a stenosis is 
detected in the coronary arteries as well. For this 
reason, it is possible to get an idea about 
atherosclerosis through IMT measurement, a non-
invasive and highly reproducible technique [8,9]. This 
means that the atherosclerotic changes in the carotid 
artery constitute an indicator of changes in the 
coronary artery as well. Carotid IMT measurement is 
recommended for people over the age of 45, and gives 
an idea about the risk of heart attack, coronary artery 
disease, or stroke that could possibly occur in this age 
group [10,11].  
Abnormal endothelium-dependent vasodilatation is 
a diffuse process; the removal of the protective effect 
provided against atherosclerosis by a normal 
endothelium leads to abnormalities in the regulation of 
the vascular tonus. Moreover, this situation might be a 
sign of increased risk of cardiovascular disease. 
Endothelial dysfunction develops as the first stage of 
the atherosclerotic process [12]. 
A tight association between brucellosis and 
cardiovascular diseases is already known. Indeed, 
cardiovascular involvement is the main cause of 
mortality due to infection with Brucella spp., and most 
commonly manifests as endocarditis, peripheral and 
cerebrovascular aneurysms, or vascular complications 
such as arterial and venous thromboses. In this study, 
we investigated the effect of brucellosis in 
atherosclerosis progression. By using FMD and IMT 
results, we attempted to investigate the long-term 
effects of brucellosis on the endothelial functions of 
patients who have had this disease. In the literature, 
we did not encounter any previous studies dealing with 
the long-term links of brucellosis with endothelial 
dysfunction and the development of atherosclerosis.  
 
Methodology 
Study protocol 
This prospective randomized clinical study was 
conducted in accordance with the Ethical Principles 
for Medical Research Involving Human Subjects as 
presented in the Declaration of Helsinki. It was carried 
out in the Application and Research Center of Baskent 
University, Konya, Turkey, after approval of the ethics 
board of the university was received. A total of 24 
patients (15 males and 9 females) who had been 
treated for acute brucellosis two years before, and who 
had had no relapses in the follow-up, were 
prospectively included in the study, along with 30 
healthy individuals (20 males and 10 females) in the 
control group. Patients between 18 and 50 years of age 
were included in the study between April 2010 and 
August 2012. After a full medical history was obtained 
for all patients, they were physically examined and 
their body mass indices (BMIs) were calculated. The 
exclusion criteria included a history of alcohol use, 
smoking, coronary artery disease in family anamnesis, 
intravenous drug addiction, pregnancy, use of 
antioxidants, hypertension, hyperlipidemia, diabetes 
mellitus, kidney or liver disease, rheumatological 
diseases, lung disease, and active infection.  
 
Laboratory analysis 
In the study, blood samples were received from the 
patients as well as from the control group to measure 
fasting blood sugar, alanine transaminase (ALT), 
creatinine, hemogram, highly sensitive C-reactive 
protein (hs-CRP), and the lipid profile, which 
comprised the total cholesterol, high-density 
lipoprotein (HDL), low density lipoprotein (LDL), and 
triglyceride levels. The blood samples were obtained 
after a night of fasting. They were collected in empty 
tubes and immediately stored on ice at 4°C. Following 
this, the serum samples were separated from the blood 
cells by being placed in the centrifuge at 3,000 rpm for 
10 minutes. The diagnoses of brucellosis were made 
by standard tube agglutination test. A possible 
correlation between the percentage increase in FMD 
and IMT was sought on the one hand, and between 
BMI, systolic and diastolic blood pressure, fasting 
blood sugar, and leukocyte count on the other.   
 
Brachial artery measurements 
FMD measurements were made in both groups. 
FMD measurement is an indicator of the endothelial 
function in the brachial artery, and abnormal values 
indicating endothelial dysfunction are accepted as the 
first stage of atherosclerosis. 
In this study, a high-resolution 7.5-MHz line-array 
ultrasound transducer (attached to a Hitachi EUB 
6500, Osaka, Japan) was used. All the measurements 
were made by a specialist who was uninformed about 
the clinical data. The patients lay prone in a silent 
room with an interior temperature of 22°C. All the 
patients were prohibited from having drinks with 
caffeine and from smoking in the last two hours 
preceding the measurements. 
For the imaging of the brachial artery, each 
patient’s arm was immobilized in a relaxed, extended 
position, and the artery was scanned longitudinally 3–
5 cm above the antecubital fossa.  
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The gain and depth adjustments were optimized to 
identify the lumen-vessel wall interface. After the 
transducer was placed in position, the skin area was 
marked as a reference point for later adjustments and 
the arm was held in the same position. Once all the 
measurements were completed, the inner diameter of 
the brachial artery was calculated, taking into account 
the QRS complex at the end of diastole; the average of 
the three consecutive measurements obtained during 
the consecutive cardiac cycle was also calculated and 
recorded. The basal measurements of the brachial 
artery were recorded. The sleeve was then placed on 
the proximal section of the brachial artery. The sleeve 
was inflated up to a pressure of 200 mm Hg (or up to 
50 mm Hg above the diastolic blood pressure), and 
held at that pressure for a duration of five minutes, 
inducing ischemia in the forearm.  
After this, the sleeve was deflated and the arterial 
diameter was measured 60 seconds after deflation. All 
these measurements were then recorded in a cassette 
for later analysis. The measurements were repeated 
while the diameter was greatest. The difference in 
percentage between the diameter measured after 
reactive hyperaemia and the basal diameter was taken 
as the FMD (FMD = 100 x [diameter after reactive 
hyperaemia - basal diameter] / basal diameter). 
The data was independently analyzed by two 
specialists at the end of the study. The intra-observer 
variabilities for the measurements of brachial artery 
diameter and flow remained below 5%. The intra-
observer intraclass correlation coefficient for the FMD 
value was 0.912. Endothelium-dependent dilatation 
was expressed in the form of a percentage change in 
the diameter of the brachial artery from baseline to 
post-reactive hyperaemia. 
 
The measurement of carotid IMT 
Carotid IMT was measured in this study by a 
previously described method, i.e., by means of high-
resolution, two-dimensional ultrasound images 
obtained with a 7.5 MHz linear-array transducer 
attached to an ultrasound machine (Hitachi EUB 6500, 
Osaka, Japan) [8]. While the subject lay in a supine 
position, longitudinal scanning was carried out from 
the common carotid artery to the bifurcation point. 
After confirming the bifurcation of the common 
carotid artery, the measurement of carotid IMT was 
performed from the far wall of the right carotid artery 
within 10 mm proximal to the bifurcation. On each 
scan, three points were measured, synchronized with 
the R-wave peaks on the electrocardiogram (ECG) to 
avoid errors that might possibly occur as a result of 
variable arterial compliance. Mean carotid IMT was 
calculated using the six measurements made from two 
scans. All the measurements were performed by a 
researcher who was not informed about the subjects’ 
clinical data. For offline analysis, the ultrasound 
images obtained were recorded on an S-VHS 
videotape. The intraobserver intraclass correlation 
coefficient for the measurement of carotid IMT was 
0.937, and the interobserver coefficient was 0.912. 
 
Statistical analysis 
Statistical analysis was done using SPSS software 
version 10. The t-test was used for the independent 
samplings, and the Chi-square test was used for the 
continuous variables. In comparing the FMD values, 
the Mann-Whitney U test was used for the non-
homogenously distributed data. The numerical values 
were expressed in the form of mean ± standard 
deviation (SD). Pearson’s test was used to determine 
the correlation between FMD, IMT, and the other 
variables. The differences were accepted as 
statistically significant whenever p < 0.05. 
 
Results 
In this study, 54 patients were assessed; 24 of them 
had brucellosis and the remaining 30 were in the 
control group. There was no statistically significant 
difference (p > 0.05) in terms of gender or age 
between the patients in the brucellosis group and those 
in the control group (Table 1).  
Similarly, there was no statistically significant 
difference between the two groups in terms of the total 
cholesterol, glucose, creatinine, ALT, LDL, HDL, 
BMI, basal systolic blood pressure, and ejection 
fraction (EF) values (Tables 1 and 2). Again, no 
statistically significant difference was found between 
the brucellosis and control group patients as far as 
leukocyte cell distribution (neutrophils, lymphocytes, 
and monocytes) was concerned.  
As for the statistically significant variables, the hs-
CRP value was 2.42 ± 1.45 in the patient group, while 
it was 1.72 ± 0.61 in the control group (p = 0.025). 
Similarly, the triglyceride value was 156.64 ± 63.89 in 
the patient group, while it was 101.73 ± 48.96 in the 
control group (p = 0.001). The HDL value was 40.68 ± 
9.56 in the patient group, while it was 47.65 ± 10.05 in 
the control group (p = 0.012). The height value was 
1.71 ± 0.08 in the patient group, while it was 1.65 ± 
0.07 in the control group (p = 0.013). The FMD value 
was 3.50 ± 1.58 in the patient group, while it was 5.88 
± 1.88 in the control group (p < 0.001). The 
percentage increase in FMD was 9.88 ± 4.92 in the 
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patient group, while it was 17.49 ± 6.37 in the control 
group (p < 0.001). The IMT value turned out to be 
0.61 ± 0.17 in the patient group, and 0.49 ± 0.12 in the 
control group (p = 0.004). All the data were found to 
be statistically significant (Tables 1 and 2). 
Furthermore, the FMD value, the percentage increase 
in FMD, and the basal radius were found to be 
correlated with hs-CRP (r = -0.644, p < 0.001; r = -
0.558, p = 0.002; r = -0.444, p = 0.018, respectively). 
The IMT values were also highly correlated with hs-
CRP (r = 0.466, p = 0.014). 
 
Discussion 
There is increasing evidence of the existence of a 
link between infection/inflammation and 
atherosclerosis [16]. Previous studies have focused on 
infections with Chlamydia pneumoniae, 
Cytomegalovirus, herpes simplex virus, Helicobacter 
pylori, and periodontitis in this context [13,14]. In 
contrast to these, various other studies have challenged 
the causal role of infectious agents in atherogenesis 
[15,16]. What current evidence does suggest, however, 
is that atherosclerosis may indeed develop in response 
to inflammatory stimuli. Accordingly, common or 
uncommon infections could well represent a risk 
factor in this regard. Some of the mechanisms that 
might be involved in cases of atherogenesis induced 
by infectious agents include a local increase of 
proinflammatory cells, a local effusion of endotoxins, 
an autoimmune reaction, a systemic cytokine release, 
or changes in the lipid metabolism [17]. The cytokine-
induced changes that take place in the lipid and 
lipoprotein metabolisms on account of infection and 
inflammation are similar [18]. 
An inflammatory response or an immune reaction 
against the Brucella antigens on the vessel wall have 
come under consideration as possible mechanisms in 
the pathogenesis of vessel involvement. The activation 
of the endothelium in response to the Brucella 
infection, as a result of the stimulation of the secretion 
of adhesion molecules and proinflammatory 
chemokines, may also play a role in the pathogenesis. 
Brucellosis may lead to cardiovascular complications, 
affecting the endothelial cells and provoking a strong 
inflammatory response [5].  
In the development of atherogenesis, arterial 
endothelial dysfunction is one of the early-stage events 
leading to the development of structural 
Table 1. Demographic characteristics of the patients 
 Brucellosis (n = 24) Control (n = 30) p 
Gender 
Male/female (n/n) 
1.32 ± 0.48 
15/9 
1.62 ± 0.50 
20/10 
0.031* 
Age (years) 39.89 ± 9.57 36.77 ± 3.57 0.116 
Height (m) 1.71 ± 0.08 1.65 ± 0.07 0.013* 
Weight (kg) 78.20 ± 12.41 72.62 ± 20.61 0.239 
Body mass index (kg/m2) 26.96 ± 4.66 26.57 ± 7.31 0.817 
Basal systolic blood pressure (mmHg) 121.07 ± 14.99 115.00 ± 14.06 0.148 
Basal diastolic blood pressure (mmHg) 78.57 ± 9.70 75.00 ± 8.59 0.175 
 
 
Table 2. Patients’ laboratory and echochardiographic results 
 Brucellosis (n = 24) Control (n = 30) p 
Total cholesterol (mg/dL) 182.25 ± 34.65 173.81 ± 26.06 0.314 
Triglyceride (mg/dL) 156.64 ± 63.89 101.73 ± 48.96 0.001* 
HDL (mg/dL) 40.68 ± 9.56 47.65 ± 10.05 0.012* 
LDL (mg/dL) 110.39 ± 31.07 109.54 ± 23.60 0.909 
Glucose (mg/dL) 98.46 ± 13.99 94.04 ± 6.62 0.141 
Creatinine (mg/dL) 0.79 ± 0.12 0.80 ± 0.13 0.639 
ALT (mg/dL) 26.14 ± 17.53 19.85 ± 11.01 0.118 
Hs-CRP (mg/L) 2.42 ± 1.45 1.72 ± 0.61 0.025* 
FMD 3.50 ± 1.58 5.88 ± 1.88 < 0.001* 
IMT 0.61 ± 0.17 0.49 ± 0.12 0.004* 
FMD (%) 9.88 ± 4.92 17.49 ± 6.37 < 0.001* 
Basal diameter 36.64 ± 5.70 34.19 ± 4.23 0.078 
Peak diameter 40.14 ± 5.78 40.08 ± 4.60 0.963 
EF (%) 67.03 ± 8.86 68.38 ± 4.69 0.490 
ALT: alanine aminotransferase; EF: ejection fraction; FMD: flow-mediated dilatation; HDL: high-density lipoprotein; hs-CRP: high-sensitivity C-reactive 
protein; IMT: carotid intima media thickness; LDL: low-density lipoprotein. 
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atherosclerotic changes. This predisposition to 
vasoconstriction and/or thrombosis is important for 
later development of obstructive atherosclerosis [19].  
Endothelium-dependent vasodilatation is realized 
through vasodilator agents such as NO. Abnormal NO 
activity is linked to atherosclerosis and vasculopathy 
[20]. The changes in NO levels may be determined 
through the measurement of the nitrite/nitrate levels in 
the plasma or indirectly through a non-invasive 
technique such as FMD measurement [21]. This 
measurement determines the vasodilator reaction 
linked to the production of endothelial NO that 
develops in reaction to the increased shear stress. 
FMD is used to detect endothelial dysfunction in 
cardiovascular diseases as well as in the presence of 
the risk factors of such diseases [7,22]. IMT is 
measured by FMD. It has been shown in previous 
studies that IMT is correlated with FMD, which is a 
good indicator of the endothelial function [23].   
Carotid IMT can be considered a general measure 
of the degree of severity of atherosclerosis, and 
increased IMT is associated with generalized 
atherosclerosis [24]. The link between carotid IMT 
and coronary atherosclerotic status has been 
demonstrated in several studies [25]. Carotid IMT 
stands today as the most established surrogate marker 
of coronary atherosclerosis. It is also the only 
noninvasive method that is acknowledged by the 
American Heart Association (AHA) to be an adequate 
surrogate marker of coronary atherosclerosis [10]. It 
was also suggested in a recently published study that 
FMD and carotid IMT taken together have still more 
predictive power as a surrogate marker of coronary 
atherosclerosis [26]. The IMT and FMD 
measurements in our study also give a good idea about 
the risk of atherosclerosis.  
 
The link between brachial FMD and carotid IMT  
It has been demonstrated by Hashimato et al. that 
there exists a significant negative correlation between 
carotid IMT and brachial endothelium-dependent 
dilation (EDD) in patients with atherosclerosis [27]. A 
recently published study by Kobayashi et al. also 
indicated that there is a significant correlation between 
carotid IMT and brachial FMD (r = -0.343, p < 
0.0001). Moreover, when FMD and carotid IMT are 
taken together, they have yet greater predictive power 
as a surrogate marker of coronary atherosclerosis [26]. 
Similarly, Paradossi et al. have found out that there is 
a significant association between carotid IMT and 
brachial FMD (r = -0.28, p = 0.002), and that it 
remains significant after multivariate analysis (r = -
0.24, p < 0.01) [28]. The IMT and FMD values 
obtained in our study corroborate the results of these 
studies. 
The hs-CRP is an acute-phase protein that is 
synthesized in the liver when the organ is stimulated 
by various cytokines, including tumor necrosis factor-
alpha and interleukin-6 [29]. Increased concentrations 
of hs-CRP in the blood suggests the presence of a 
bacterial infection and high levels of hs-CRP have 
been reported as an early indicator of such infections 
[30,31]. Moreover, there are other circumstances that 
cause important changes in hs-CRP concentrations. 
Normally, the hs-CRP levels begin to rise two to three 
days after the stimulus, reach a peak approximately 50 
hours after it, and then begin to fall again. The exact 
timing depends on how fast the inflammatory process 
develops [32]. 
Considering that no such study had been 
conducted before on brucellosis patients, we measured 
the hs-CRP levels and FMD simultaneously. Our study 
revealed the existence of a significant link between the 
hs-CRP and FMD values. The fact that our study 
revealed a difference in the hs-CRP values between 
the patient and control groups, with higher values 
observed in the former group, is an indicator of the 
ongoing inflammatory process. The study also showed 
that the endothelium-dependent vasodilatation values, 
as measured by FMD, were abnormal. It was observed 
further that FMD, one of the noninvasive means of 
assessing atherosclerosis, as well as the basal 
percentage increase and the basal diameter, were 
correlated with high hs-CRP values. 
There is very limited information on the serum 
lipid profile of brucellosis patients [33]. It has been 
demonstrated in previous studies that the lipids are 
altered in infected patients. The major part of the 
studies on humans focused on patients with sepsis 
[34]. 
It is well known that cholesterol levels decrease 
during infections, but the mechanisms underlying this 
phenomenon are unclear. Several studies have 
demonstrated that there is a correlation between the 
reduction in cholesterol levels as well as the alterations 
in apolipoprotein concentrations on the one hand, and 
certain cytokine and acute phase protein levels on the 
other. Various studies have shown the existence of 
such correlations in patients with sepsis [35] and in 
neutropenic patients with fever as well as in normal 
volunteers after a single intravenous endotoxin 
injection [36]. In addition, studies of patients with 
AIDS [37] and critically ill surgical patients [38] have 
also revealed such associations. Among these are 
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reductions in the serum levels of total cholesterol, 
HDL and LDL, as well as increases in triglycerides 
[39]. According to current evidence, the response of 
the host to infection and inflammation leads to an 
increase in oxidized lipids in serum, and brings about 
LDL oxidation in vivo. Oxidative modification of LDL 
is one of the important events leading to the 
development of atherosclerosis [37,40]. According to 
the study of Apostolou et al., the total cholesterol and 
triglyceride levels significantly increased, the HDL 
levels were suppressed, and the magnitude of these 
changes were observed to remain high over a four-
month time period [40]. In our study, the triglyceride 
value was found to be high in patients who had had 
brucellosis, while the HDL value was found to be low. 
In contrast to the study of Apostolou et al., we found 
that total cholesterol was normal.  
The evidence at hand suggests that Brucella 
infection might be linked with an atherogenic lipid 
profile. Considering the lipid profile values of the two 
groups compared in our study, it was observed that the 
differences in the triglyceride and HDL values were 
correlated with the abnormalities in FMD 
measurements, and constituted determining factors in 
atherosclerosis. 
 
Study limitations 
In this study, the number of patients was not 
sufficient. Moreover, interleukin-6, tumor necrosis 
factor, catecholamines, and reactive oxygen species 
could not be taken into consideration. To test the 
validity of our study, we recommend epidemiological 
studies focusing on the link between brucellosis and 
coronary artery disease. 
 
Conclusions 
Brucellosis was found to be a risk factor for 
coronary artery disease on account of the peripheral 
endothelial dysfunctions that develop in patients with 
this infection. The abnormal FMD and IMT values 
observed in brucellosis patients might be an indicator 
of more frequent arterial dysfunction, increased 
cardiovascular risk, and atherosclerosis. Moreover, we 
believe that brucellosis contributes to the development 
of coronary artery disease by altering the lipid profile 
(reduced HDL, increased triglycerides). This suggests 
that brucellosis is a preparative factor in the 
development of atherosclerosis. When the known and 
unknown risk factors of atherosclerosis are taken into 
account, it appears that FMD and IMT measurement 
might constitute a sensible method for identifying 
individuals at a high risk of cardiovascular disease and 
for taking active preventive measures.   
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